These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 18410592)

  • 1. Regulatory T-cell immunity and its relevance to atherosclerosis.
    Taleb S; Tedgui A; Mallat Z
    J Intern Med; 2008 May; 263(5):489-99. PubMed ID: 18410592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T-cell immunity in atherosclerosis.
    Mallat Z; Ait-Oufella H; Tedgui A
    Trends Cardiovasc Med; 2007 May; 17(4):113-8. PubMed ID: 17482092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
    George J
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive T cell immune responses and atherogenesis.
    Taleb S; Tedgui A; Mallat Z
    Curr Opin Pharmacol; 2010 Apr; 10(2):197-202. PubMed ID: 20207195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of foxp3+ T regulatory cell-mediated suppression.
    Shevach EM
    Immunity; 2009 May; 30(5):636-45. PubMed ID: 19464986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
    Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
    J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding and converting regulatory T cells: a horizon for immunotherapy.
    Khattar M; Chen W; Stepkowski SM
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticity of CD4+ T cell lineage differentiation.
    Zhou L; Chong MM; Littman DR
    Immunity; 2009 May; 30(5):646-55. PubMed ID: 19464987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural regulatory T cells control the development of atherosclerosis in mice.
    Ait-Oufella H; Salomon BL; Potteaux S; Robertson AK; Gourdy P; Zoll J; Merval R; Esposito B; Cohen JL; Fisson S; Flavell RA; Hansson GK; Klatzmann D; Tedgui A; Mallat Z
    Nat Med; 2006 Feb; 12(2):178-80. PubMed ID: 16462800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells in atherogenesis: for better or for worse?
    Robertson AK; Hansson GK
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2421-32. PubMed ID: 16973967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of T helper and T regulatory cell responses at birth.
    Schaub B; Liu J; Schleich I; Höppler S; Sattler C; von Mutius E
    Allergy; 2008 Nov; 63(11):1438-47. PubMed ID: 18925880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines in atherosclerosis: pathogenic and regulatory pathways.
    Tedgui A; Mallat Z
    Physiol Rev; 2006 Apr; 86(2):515-81. PubMed ID: 16601268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?
    Curotto de Lafaille MA; Lafaille JJ
    Immunity; 2009 May; 30(5):626-35. PubMed ID: 19464985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of T-regulatory cells in cord blood of atopic mothers.
    Schaub B; Liu J; Höppler S; Haug S; Sattler C; Lluis A; Illi S; von Mutius E
    J Allergy Clin Immunol; 2008 Jun; 121(6):1491-9, 1499.e1-13. PubMed ID: 18539197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.